JAMA Neurology Add us as a preferred source on Google
🔄 Data last refreshed 7 days ago
🤝
Make a deal with JAMA Neurology
🔒 Paid proposals held safely in escrow — released only when the work's approved.
Followers
67.7K
Posts
15.3K
Following
240
Account age
17 yrs
💰 Suggested sponsorship rate
$379 – $616 / sponsored post
Estimated from audience size & typical reach — every deal is negotiable and held in SocialDB escrow.
🎁 Free analysisfor JAMA Neurology
Known for
75.2K views
TRAILBLAZER-ALZ 2: Among patients with early symptomatic #AlzheimerDisease and amyloid and tau pathology, donanemab treatment significantly slowed clinical progression at 76 weeks.
https://t.co/evvC0dvxrh
#AAIC23
60.8K views
In patients with ischemic stroke and concurrent nonvalvular atrial fibrillation and ASCVD, adding an antiplatelet agent to anticoagulant therapy offered no net clinical benefit over anticoagulant monotherapy.
https://t.co/sufWnioRQq
49.9K views
In this trial, among patients with aneurysmal subarachnoid hemorrhage, lumbar drainage improved clinical neurological outcomes at 6 months. https://t.co/SZjuQoGoku
32.9K views
In this meta-analysis, seizure prophylaxis was effective for mild and moderate TBI to reduce rates of early seizures. https://t.co/CTa5cnME4S
📊 Post performance
Recent posts · views
May 12latest
23.7K
Avg views / post
14.2K–32.9K
Typical post (views)
35%
Reach vs followers
70/100
Consistent reach
Jul 2009
On X since
Half of recent posts land between 14.2K and 32.9K views (median 24.1K) — a dependable floor a sponsored post can count on.
🔥 Top post: TRAILBLAZER-ALZ 2: Among patients with early symptomatic #Alzhei · 75.2K views
📊 Activity & format
Posting cadence
0.05 / week
A lower-frequency account — each post lands with more weight.
Content mix
Mostly images
Recent: 0 video · 14 image · 4 text.
Follower / following
282×
Follows 240 back. A strong ratio — an audience that follows them, not a follow-for-follow network.
Recent posts
View on X ↗
🔥 Top post
TRAILBLAZER-ALZ 2: Among patients with early symptomatic #AlzheimerDisease and amyloid and tau pathology, donanemab treatment significantly slowed clinical progression at 76 weeks.
https://t.co/evvC0dvxrh
#AAIC23
In patients with ischemic stroke and concurrent nonvalvular atrial fibrillation and ASCVD, adding an antiplatelet agent to anticoagulant therapy offered no net clinical benefit over anticoagulant monotherapy.
https://t.co/sufWnioRQq
The VasCog-2-WSO criteria provide updated international guidelines for diagnosing vascular cognitive impairment and #dementia, incorporating recent biomarker advancements. https://t.co/2KLr8NTQgr
Belly dancer’s dyskinesia (BDD) is a rare movement disorder involving involuntary abdominal muscle contractions, potentially linked to central nervous system issues.
Learn more in this case report: https://t.co/TKTo1RvYfx
Recurrent intracerebral hemorrhage (ICH) adjacent to a previous ICH is a phenomenon associated with early recurrence and features of cerebral amyloid angiopathy. https://t.co/PqDbbi62zm
Apixaban compared to aspirin was associated with fewer incident nonlacunar covert infarcts among patients with a recent cryptogenic ischemic stroke and atrial cardiopathy. @sheth_kevin https://t.co/Y17tAVubPL
The clinical spectrum of anti-GQ1b antibody syndrome continues to expand to include acute vestibular syndrome, optic neuropathy, and acute sensory ataxic neuropathy in addition to classic syndromes. https://t.co/2z3WAXbTZt #MFS #GQ1b #Opht…
No significant difference found between anticoagulants and antiplatelets in early secondary prevention of stroke after cervical artery dissection, finds meta-analysis. https://t.co/xUpAR94cNU
In this meta-analysis, seizure prophylaxis was effective for mild and moderate TBI to reduce rates of early seizures. https://t.co/CTa5cnME4S
Review article illustrates the current, and likely future, landscapes of prognostic markers of neurologic recovery from disorders of consciousness caused by severe, acute brain injury. https://t.co/Iv7UdDck53
Patients with benign paroxysmal positional vertigo may recover more quickly using the Semont-plus maneuver rather than the Epley maneuver.
In this trial, among patients with aneurysmal subarachnoid hemorrhage, lumbar drainage improved clinical neurological outcomes at 6 months. https://t.co/SZjuQoGoku
💡 Facts
🗓️Joined X in 2009 — 17 years ago.
👁️Averages 23.7K views per post.
📤Posts about 0.1× per week.
💬0.41% engagement rate.
🏅Earned the 10K Followers for passing 10K followers.
🕵️ Fake follower check
Estimated37/100
Low
Credibility score
66%
Mixed
Real audience
Medium
Fake-follower risk
High
Data confidence
- Est. 66% real, active audience · Medium fake-follower risk.
- Low engagement (~0.4× of followers engage each post) — a sign of an inflated or inactive audience.
- Organic base — far more followers than accounts it follows.
- Established account (17+ years old).
- 0.41% engagement — below the ~8.8% typical for this size.
Heuristic estimate from engagement, follower ratios, account age & growth — a screening signal, not a guarantee.
About
JAMA Neurology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.
📸 Gallery
🔀 Audience overlap
EstimatedEstimated shared audience with similar creators — useful for avoiding overlap (or doubling down) when planning a campaign.
#bullshitjobs
17%
Muhammad Junaid Zafar
17%
Kygo
14%
AFC Bournemouth 🍒
11%
GOLFTV
11%
Mark Dalgleish
10%
More like this
Find more →
Frequently asked questions
How much does JAMA Neurology charge for a sponsorship?
JAMA Neurology hasn't published fixed prices yet. Send a proposal through SocialDB and agree terms directly — your payment is held in escrow until the work is approved.
How do I contact JAMA Neurology for a brand deal or collaboration?
Send a paid deal or collab request right here on SocialDB — we notify JAMA Neurology, and once they accept, your payment is held safely in escrow and released when the work is approved. You don't need to track down an email.
How many followers does JAMA Neurology have?
JAMA Neurology has 67,716 followers on X.
✉ Message JAMA Neurology
Reaching out to influencers is a Pro feature. Upgrade to message any influencer directly — perfect for brands and agencies booking sponsorships.
- ✓ Message any influencer from their listing
- ✓ The influencer gets notified by email
- ✓ Manage every conversation in one inbox
Already Pro? Log in.
🎤 Event / appearance with JAMA Neurology
Booking an event / appearance is a Pro feature. Upgrade to book JAMA Neurology for an in-person or virtual appearance — payment held safely in escrow until the event is done.
- ✓ Book them for events, livestreams, panels & more
- ✓ JAMA Neurology gets notified by email
- ✓ Fee held in escrow, released after the appearance
Already Pro? Log in.
🚀
You're out of free requests this month
Free accounts get 5 per month. Go Pro for unlimited sponsor pitches, collab requests & sponsorship deals — plus featured placement, the Verified badge, free withdrawals and more.
Upgrade to Pro — $9.95/mo →Your free limit resets on the 1st of next month.
Auto-generated from X's public data — no affiliation with or endorsement by SocialDB. Is this you? Claim it · Remove